Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Roche Scraps Global Diversity Targets Amid U.S. Executive Orders Impacting Corporate Policy

Roche Scraps Global Diversity Targets Amid U.S. Executive Orders Impacting Corporate Policy

ECHEMI 2025-03-20

In a significant shift, Swiss pharmaceutical giant Roche has announced the abandonment of its global diversity targets due to concerns over recent U.S. executive orders. This decision reflects a broader trend among companies adjusting their diversity, equity, and inclusion (DEI) initiatives in response to regulatory pressures.


Roche's Chief Diversity Offices in both the U.S. and Basel will now prioritize inclusion and belonging, with their responsibilities being redefined. Notably, diversity has been omitted from their new objectives, indicating a strategic pivot designed to ensure compliance. According to an internal memo shared with employees, these changes are essential for Roche to continue delivering vital medicines and diagnostic solutions to patients.


This move comes as several U.S. companies have begun scaling back their DEI programs following directives from the Trump administration, which deemed certain aspects of these initiatives illegal. In a similar vein, UBS, a Swiss bank, recently removed references to promoting women and ethnic minority hiring from its annual report, highlighting the widespread impact of these executive actions.


Roche's decision to eliminate its diversity targets will also extend beyond the U.S., as the firm recognizes that global policies can influence operations in America, necessitating compliance with new legal frameworks. This reevaluation of diversity initiatives underscores the complexities and challenges companies face in maintaining inclusive practices while navigating shifting political landscapes.


As Roche adapts to these changes, the implications for its workforce and corporate culture remain to be seen, raising questions about the future of diversity in the pharmaceutical industry. This development serves as a critical reminder of the evolving relationship between corporate policies and governmental regulations, prompting industry leaders to rethink their strategies in an increasingly complex environment.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.